Ionic Silver Complex Designed for Antimicrobial Use in Humans Receives U.S. Patent
Invision International Health Solutions, Inc., a pioneer in the field of ionic silver use as an antimicrobial in humans, announced the issuance of a U.S. Patent on its "ionic silver complex" technology.
The use of ionic silver in medicine and industry has been growing rapidly in recent years due to its broad-spectrum antimicrobial qualities, the lack of toxicity to humans and the fact that ionic silver is not prone to causing resistant strains. Ionic silver is well known to be a very powerful and very broad-spectrum antibacterial agent. In addition, evidence is mounting that silver ions have powerful antiviral effects as well. A recent university study suggested ionic silver to be effective against the SARS virus. In Europe, ionic silver is a medically approved treatment used to combat systemic viral conditions, including the common cold and flu.
Silver ion compounds have been introduced in recent years for antimicrobial use in food-handling materials, medical devices, surface disinfectants, wound-care products, industrial materials, textiles, and more. In all cases, the key is the carrier agent that is used to stabilize the silver ions and "time release" them at the desired location in the given environment.
The patented technology is designed to utilize naturally occurring substances, such as citrate, to achieve optimal delivery and release of silver ions in the human body, in a highly efficient and entirely safe manner. Silver ions, while being lethal to single-celled microorganisms, are harmless to human cells and, in fact, are increasingly being used in wound care due to their remarkable ability to facilitate the healing of tissue. The patented technology provides for a completely safe product due to the efficient delivery, introducing a minute quantity of silver to the body -- less than what may exist in a person's average drinking water intake as a naturally occurring mineral. The difference is that this new technology is designed to deliver the silver as active silver ions with antimicrobial ability.
Most read news
Topics
Organizations
Other news from the department research and development

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Bayer Technology Services to build chlorine drying unit for BorsodChem in Hungary
Ian Davis to Join the BP Board

Targets for 2030: WACKER Accelerates Growth with High Profitability - Growth will double, sales should exceed €10 billion

Weyl fermions discovered in another class of materials

New lithium battery with simple production and high safety developed - "This study underscores the importance of molecular structure design in creating effective additives for quasi-solid-state electrolytes"
Chemical element 112 is named 'Copernicium' - The name proposed by GSI for the heaviest chemical element has been officially endorsed
Producing Gold nanocrystals with defined geometric shapes
Tomah names DoveChemCentral and RishiChem as new Distributors

Solving a mystery - A new model for understanding how certain nuclei split

Device combines power of mass spectrometry, microscopy
BASF acquires filament producer Innofil3D
